27 Aug. 2026, 13:00-16:00 PhD defence: Development of CRISPR-based Technologies to Define Disease Predisposition Casper Carstens Lund is defending the PhD thesis: Development of CRISPR-based Technologies to Define Disease Predisposition and Drug Response of Hereditary Cancer Genes and Variants.
